Elekta (OTCMKTS:EKTAY) Upgraded at Zacks Research

Zacks Research upgraded shares of Elekta (OTCMKTS:EKTAY) from a strong sell rating to a hold rating in a report published on Tuesday,Zacks.com reports.

Other equities research analysts also recently issued research reports about the stock. Danske downgraded shares of Elekta to a “hold” rating in a research report on Tuesday, June 3rd. UBS Group started coverage on shares of Elekta in a research report on Wednesday, September 3rd. They issued a “sell” rating for the company. Three equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Elekta currently has a consensus rating of “Reduce”.

Elekta Trading Up 2.6%

OTCMKTS:EKTAY opened at $5.38 on Tuesday. The company has a current ratio of 1.05, a quick ratio of 0.82 and a debt-to-equity ratio of 0.63. Elekta has a 12 month low of $4.36 and a 12 month high of $7.13. The company has a market cap of $1.98 billion, a PE ratio of 89.68 and a beta of 1.10. The company has a 50 day simple moving average of $4.97 and a two-hundred day simple moving average of $5.09.

Elekta (OTCMKTS:EKTAY) last posted its earnings results on Thursday, August 28th. The company reported $0.03 EPS for the quarter. Elekta had a net margin of 1.40% and a return on equity of 11.49%. The business had revenue of $379.64 million during the quarter. Research analysts forecast that Elekta will post 0.36 earnings per share for the current year.

Elekta Dividend Announcement

The company also recently announced a dividend, which will be paid on Friday, September 26th. Investors of record on Tuesday, September 9th will be paid a dividend of $0.0744 per share. The ex-dividend date is Monday, September 8th. This represents a dividend yield of 289.0%. Elekta’s payout ratio is 216.67%.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.